- Research article
- Open Access
A forward genetic screen with a thalamocortical axon reporter mouse yields novel neurodevelopment mutants and a distinct emx2 mutant phenotype
Neural Development volume 6, Article number: 3 (2011)
The dorsal thalamus acts as a gateway and modulator for information going to and from the cerebral cortex. This activity requires the formation of reciprocal topographic axon connections between thalamus and cortex. The axons grow along a complex multistep pathway, making sharp turns, crossing expression boundaries, and encountering intermediate targets. However, the cellular and molecular components mediating these steps remain poorly understood.
To further elucidate the development of the thalamocortical system, we first created a thalamocortical axon reporter line to use as a genetic tool for sensitive analysis of mutant mouse phenotypes. The TCA-tau-lacZ reporter mouse shows specific, robust, and reproducible labeling of thalamocortical axons (TCAs), but not the overlapping corticothalamic axons, during development. Moreover, it readily reveals TCA pathfinding abnormalities in known cortical mutants such as reeler. Next, we performed an unbiased screen for genes involved in thalamocortical development using random mutagenesis with the TCA reporter. Six independent mutant lines show aberrant TCA phenotypes at different steps of the pathway. These include ventral misrouting, overfasciculation, stalling at the corticostriatal boundary, and invasion of ectopic cortical cell clusters. An outcross breeding strategy coupled with a genomic panel of single nucleotide polymorphisms facilitated genetic mapping with small numbers of mutant mice. We mapped a ventral misrouting mutant to the Emx2 gene, and discovered that some TCAs extend to the olfactory bulbs in this mutant. Mapping data suggest that other lines carry mutations in genes not previously known for roles in thalamocortical development.
These data demonstrate the feasibility of a forward genetic approach to understanding mammalian brain morphogenesis and wiring. A robust axonal reporter enabled sensitive analysis of a specific axon tract inside the mouse brain, identifying mutant phenotypes at multiple steps of the pathway, and revealing a new aspect of the Emx2 mutant. The phenotypes highlight vulnerable choice points and latent tendencies of TCAs, and will lead to a refined understanding of the elements and interactions required to form the thalamocortical system.
See Commentary: http://www.biomedcentral.com/1741-7007/9/1
The conscious perceptions and actions mediated by the cerebral cortex are transmitted and modulated through axonal connections with its intimate processing partner, the dorsal thalamus. These reciprocal projections, the thalamocortical and corticothalamic axons, develop in concert by growing in opposite directions along the same pathway . Some disorders such as epilepsy or schizophrenia may involve defects in the architecture of the thalamocortical system [2–4], but the mechanisms of its development remain poorly understood.
Humans and mice share a similar organization of the thalamocortical system. The elaborate guidance process of thalamocortical axons (TCAs) in rodents can be broken into six key steps (Figure 1A; detailed reviews in [5–7]). First, the axons extend ventrally along the side of the thalamus. Second, near the hypothalamus, they turn laterally to cross the diencephalon-telencephalon border (DTB) and enter the ventral telencephalon around embryonic day (E)13 . This step appears to require repulsion from Slit in the ventral thalamus [9–11], and interactions with a cluster of 'guidepost cells' in the internal capsule [12–14]. Sema6A is required by a subset of TCAs for the lateral turn, but the mechanism is not understood [15, 16]. Third, the large single bundle of TCAs fans out and extends as numerous fascicles through ventral telencephalon (vTel). This extension through vTel may be guided by a permissive 'corridor' of tangentially migrating cells that express the attractant neuregulin-1 . Moreover, the spreading of the TCA array is topographically organized by gradients of cues in the vTel [18–21]. Fourth, the TCA fascicles cross the corticostriatal boundary (CSB) around E15 and turn dorsally. The factors mediating this crossing are unknown, but may be disrupted in mutants for the transcription factors Tbr1 or Fezf2 [22–25]. Fifth, once in the cortex, the TCAs elongate within the intermediate zone and/or subplate [26–28]. Finally, around birth, TCAs sprout collateral branches within their specific cortical target areas to synapse with layer 4 neurons [27, 29]. The TCAs thereby transmit topographic sensory information to the appropriate cortical areas.
Since the understanding of the steps and mechanisms of TCA development remains fragmentary, we performed an unbiased forward genetic screen to identify genes required for thalamocortical development. We combined efficient mutagenesis and mapping strategies [30–32] with a specific axonal reporter, TCA-tau-lacZ (TCA-TLZ), to visualize and screen for proper formation of this axon tract inside embryonic mouse brains, without sectioning or immunohistochemistry. Seven independent cortical development phenotypes were found, six with aberrant TCA projections. Initial mapping determined that one mutation was in Emx2, while others represent novel genes for this process.
The TCA-TLZ reporter line labels thalamocortical axons during development
The TCA-TLZ transgenic reporter line was created fortuitously by pronuclear injection and random genomic insertion of a transgene containing the golli promoter driving the tau-lacZ reporter gene. This reporter fuses the axonal tau microtubule binding protein to beta-galactosidase to localize it to axons . The golli promoter is a portion of the myelin basic protein promoter that was shown to promote expression in deep cortical layer neurons . Surprisingly, in this line, the tau-lacZ was expressed not in the cortex but instead in dorsal thalamus. The unexpected pattern is presumably due to positional effects of unknown enhancers at the insertion site, mapped to an 8.5-Mb interval of about 45 genes on chromosome 3 (data not shown). The insertion does not appear deleterious: homozygotes are viable and fertile, with no detectable abnormal phenotypes in brain morphology or TCA patterning at birth (n > 40).
The TCA-TLZ reporter line expresses the axonal reporter tau-beta-galactosidase in the cell bodies and axons of dorsal thalamic neurons. These neurons are born between E10 and E13 in mice . Expression of the TCA-TLZ transgene is detectable from E13.5 onwards, allowing visualization of TCAs during prenatal development, as they project through vTel and innervate the cortex (Figure 1A). (In this paper, the term 'ventral telencephalon' or vTel refers to the region extending from the ventral surface to the lateral ventricle, including the ganglionic eminences, and the forming basal ganglia and amygdala.) No cortical axons are labeled, although scattered cell bodies in the cortex stain postnatally (Figure 1A, postnatal day (P)9.5). The tau-beta-galactosidase labels axons strongly enough to be visible to the naked eye in whole brains (Figure 1C-F). Importantly, the transgene is expressed in the same pattern consistently across different individuals, generations, and genetic backgrounds: in dorsal thalamus, not ventral thalamus (Additional file 1), and in a small number of other neuronal tracts and populations, including the optic tract (Figure 1C, ot), the accessory olfactory bulb and accessory lateral olfactory tract (LOT), the pontocerebellar tract (PCT), and the outer external granular layer of early cerebellum (Figure 1F).
The TCA-TLZ reporter can reveal the TCA pathfinding and cortical lamination defects found in the reeler mutant
To test whether the TCA-TLZ reporter can reveal TCA guidance and cortical morphogenesis phenotypes, it was crossed to the well-known cortical lamination mutant reeler (Figure 2). In reeler mutant brains, cortical layers are roughly inverted, and the subplate cells remain superficial . The TCA-TLZ reporter shows that in control brains at P0 (Figure 2AA'), the TCAs had entered the cortex and could be seen as a dark blue bundle growing in a restricted zone defined by the subplate (Figure 1A', sp), above the mitotic layer and beneath the cortical plate. The collateral branches, thin perpendicular offshoots from the axon shafts, were seen as a lighter blue haze in the deep half of the cortical plate (Figure 1A', br). By contrast, in reeler mutant brains, the TCAs did not extend beneath the cortical plate, but grew obliquely across it (Figure 2B, B'), to reach the displaced subplate (sometimes called the superplate, sp*). The appearance of the TCAs in these reeler mutants matched that seen with dye tracing previously [28, 36]. This experiment demonstrates that the TCA-TLZ reporter can readily reveal both the abnormal TCA pattern and the aberrant cortical layering in the reeler mutant, and may be an extremely useful readout of forebrain development abnormalities and tool for analysis of other thalamocortical projection mutants.
A genetic screen focused on thalamocortical development
To discover novel genes and phenotypes in thalamocortical development and forebrain morphogenesis, we employed an efficient screening and mapping strategy previously used to identify mouse models of human birth defects [30, 32]. First, a three generation breeding strategy of two intercrosses followed by a backcross allowed for efficient collection of recessive mutants and concurrent mapping (Figure 3A). Second, screening was performed on the day before birth so that all of prenatal cortical development could be assayed, but mutations causing postnatal lethality could still be collected. This was important since several mouse knockouts affecting thalamocortical development die at birth. Third, initial mapping was accomplished relatively rapidly through the use of an autosomal genome panel of SNP markers . Finally, incorporating the TCA-TLZ reporter into the scheme enhanced detection and description of prenatal thalamocortical phenotypes.
Males carrying the TCA-TLZ transgene on a C57BL/6 background were mutagenized with N-ethyl-N-nitrosourea (ENU) and mated to wild-type females of the FVB/N strain. G1 males carrying the TCA-TLZ transgene were bred to wild-type FVB/N females, and the resulting G2 daughters were backcrossed to their fathers and sacrificed at embryonic day E18.5 to harvest G3 embryos for screening (Figure 3A and Materials and methods). Embryo brains were cut in half coronally, stained for beta-galactosidase, and examined as whole-mounts. All brains were checked for morphology, and those carrying the transgene (approximately 63%) were examined for abnormalities in the TCA pattern. Five to eight litters from each G1 line were screened. The repeated observation of a specific phenotype in independent litters, followed by faithful transmission after further outcrosses, indicated a high likelihood the abnormality was caused by a monogenic mutation .
We screened 57 G1 lines, each representing an independently mutagenized haploid autosomal genome derived from a single G0 sperm. The X chromosome was not assayed in this screen because males were mutagenized and only their male progeny were bred. Seven independent recessive brain development mutants were found, and six of these showed defects in thalamic axons (Table 1 and following sections). Several mutations caused pleiotropic phenotypes, affecting more than one tissue, and three additional mutant lines had only non-brain phenotypes (see Materials and methods). Mutant lines not selected for analysis included a few with exencephaly or embryonic lethal phenotypes. Only those lines that behaved as recessive Mendelian, highly penetrant phenotypes were mapped.
Since the screen was done as an intercross between the inbred strains C57BL/6 and FVB/N (Figure 3A), genetic mapping by analysis of meiotic chromosomal recombination could be done directly with DNA from affected progeny. By genotyping mutants for a genome-wide panel of up to 768 SNPs that are polymorphic between C57BL/6 and FVB/N, analysis of small numbers of mice resulted in mutation localization to chromosomal intervals of approximately 40 Mb . Microsatellite (simple repeat) markers were then used to confirm and narrow the SNP intervals.
Mutants display defects at various steps in the TCA projection
The thalamocortical screen revealed several mutant lines with TCA defects visible at low magnification in stained E18.5 brains. TCAs were disrupted at various steps along their pathway (Figure 3B-I). Additionally, several mutants had morphological defects (Table 1), and all were postnatal lethal. The ND21 mutant had normal TCA patterning but a small brain, and is described elsewhere as a mutant in the Golgi protein GMAP210 .
Three mutants were found with similar TCA phenotypes at Step 2 of the pathway, in which a subset of TCAs failed to turn laterally upon crossing the DTB (Figure 3C-E). In fuddle, magoo, and wanderer mutants, a single bundle of TCAs was oriented ventrally from the internal capsule just after crossing the DTB, while the remainder of TCAs appeared to navigate normally to the cortex. In the fuddle mutant line, the misrouted fascicles were very thin (Figure 3C, arrow), while those observed in magoo and wanderer appeared thicker with presumably more axons (Figure 3D, arrows). These turning errors could represent failures to detect or respond to ventral repellents, or defects in the interactions with internal capsule guidepost cells. All fuddle mutants displayed enlarged lateral ventricles and hippocampal hypoplasia, suggesting other defects in forebrain development. About one-fourth had a TCA defect, and about one-fourth also displayed subtle eye abnormalities, such as irregular irises. The fuddle phenotypes co-segregated across generations and mapped to the same region of chromosome 19, indicating that they are all caused by the same mutation.
Steps 3 and 4, in which TCAs spread through vTel and cross the CSB, appeared abnormal in sprawl and baffled mutants. In both of these mutants, some TCAs were overfasciculated and stalled (Figure 3F). Fewer axons entered the cortex. This phenotype could represent a defect in axon defasciculation from one large bundle to many smaller bundles, or a problem with recognizing the corridor cells or other cues that guide the TCAs through the ventral telencephalon. The baffled mutant defect was more dramatic, and seemed most suggestive of a defect in step 4, crossing the CSB (also called the pallial-subpallial boundary). The baffled thalamic axons appeared disorganized in the lateral vTel and most failed to enter the cortex (Figure 3G, red arrows).
The bumpy mutant phenotype may represent an indirect effect on step 5, the restriction of TCAs beneath the cortical plate. The surface of the bumpy mutant forebrain had ectopic lumps of cells outside the pia (Figure 3H-I, red arrows). Cortical lamination appeared disorganized beneath these ectopia. This phenotype is reminiscent of the human brain malformation known as cobblestone (type II) lissencephaly, also called Walker-Warburg syndrome, which is due to cortical neuron over-migration past the marginal zone . Interestingly, a small number of TCAs crossed the cortical plate to invade the 'cobblestones' (Figure 3H, upper red arrow; zoomed in Figure 3H'). Thin sections through cortical ectopia showed they contained both cells erupted through the marginal zone (Figure 3I, red arrow) and axonal fibers (Figure 3I', red arrow). This finding suggests that the misplaced cells may express substrates attractive to TCAs, or that the same mechanism that normally prevents neuron overmigration also acts on TCAs to keep them from invading the cortical plate inappropriately. Axonal innervation of cobblestone-type ectopia has not been shown before in human patients or mouse models, but aberrant cortical wiring could help explain varying seizure phenotypes of some type II lissencephaly patients [39, 40].
magoo mutants have small brains and craniofacial defects along with a TCA ventral misrouting defect
magoo mutants showed a ventral misrouting defect of TCAs. Out of ten magoo mutant embryos stained and expressing the TCA-TLZ reporter, three displayed a small subset of TCAs turned ventrally out of the internal capsule (Figure 3D, arrow). The misrouted bundle appeared to turn ventrally just after the DTB, and then curve slightly rostrally and stop. L1 antibody, which marks several forebrain tracts, including TCAs and corticothalamic axons (Figure 4A), appeared to confirm the ventral misrouting, showing an aberrant thick bundle of axons extending ventrally from the internal capsule along the vTel side of the DTB (Figure 4B, red arrow). The TCAs that did grow to the cortex in the mutant showed no other apparent abnormalities, although the mutant cortex was thinner, with a thinner axonal layer (Figure 4B). Indeed, the entire forebrain was reduced in size in every homozygous magoo mutant, but severity varied (Figure 4C). Seventy-one percent (35 of 49) of magoo brains were categorized as mild, with only slightly small forebrains (for example, Figure 4C, middle), and the other 29% (14 of 49) were categorized as severe, with hypoplasia of all brain regions (extreme example in Figure 4C, right). Interestingly, the two cortices or olfactory bulbs in a given individual mutant brain were sometimes asymmetric in size (for example, see olfactory bulb asymmetry in Figure 4C, middle). This variability within two halves of one organ suggests that stochastic events underlie the phenotypes. It is not clear whether the TCA defect is cell autonomous or secondary to changes in the forebrain pathway.
In addition to small forebrain size, magoo mutants often had craniofacial and eye abnormalities (Figure 4D, E). The snout was usually shortened (76%; 35 of 46), often with cleft palate (24%; 10 of 42). Most mutants had eye phenotypes on one or both sides ranging from iris coloboma to microphthalmia (83%; 38 of 46). Internal organs below the neck appeared normal and proportional to body size, but digits were abnormal in 13% of homozygous mutants (7 of 53). Heterozygotes were indistinguishable from wild types. The phenotypes could indicate a primary defect in patterning, proliferation, or cell migration. However, even in the mildest magoo mutants with no craniofacial defects, the forebrain was still slightly small, suggesting that forebrain tissue is the most vulnerable to the loss of this gene.
The magoo mutant gene appears to be novel. The mutation was mapped using SNP and microsatellite markers to a small region on chromosome 19 between D19Mit135 and D19Mit12, which does not contain any known thalamocortical development genes. In addition, since the magoo map interval overlapped with the larger fuddle interval on chromosome 19, and both had a ventral misrouting TCA defect, we tested whether they were allelic by complementation. In five intercross litters, none of 40 embryos showed brain morphology or TCA phenotypes, suggesting that the magoo and fuddle mutations are in different genes.
The baffled mutant shows severely reduced thalamocortical innervation
In contrast to the partial TCA defect seen in magoo, the baffled mutant showed a fully penetrant and severe TCA phenotype (Figure 3G and 5). As seen from dorsal views of whole brains, wild-type cortices stained blue from innervating TCAs (Figure 5A, left), but baffled mutant cortices had greatly reduced cortical staining, suggesting less TCA innervation (Figure 5A, right). While the cortex and olfactory bulbs of baffled mutants usually appeared slightly smaller than littermates', they were not misshapen.
Coronal cuts revealed why baffled mutants had fewer TCAs in the cortex. Control brains showed a parallel array of TCAs traveling through the lateral vTel, and curving neatly to cross the CSB into the cortex (Figure 5B). By contrast, in baffled mutant brains (Figure 5C), the TCAs appeared tangled in the lateral vTel, and some seemed to be stalled in masses near the CSB (Figure 5C, red arrow). Lipophilic dye placements into dorsal thalamus (dTh) to trace TCAs showed a very similar result (Figure 5DE). Similarly, L1 antibody staining (Figure 5FG) confirmed that axon fascicles were disorganized in lateral vTel (5G, arrows), and thickened near the CSB (5G, arrowheads). To examine these axon bundles in cross-section, thin sagittal sections were taken from the lateral cortex of control and mutant brains and stained with hematoxylin and eosin (Figure 5HI). In the lateral cortex near the CSB, the control brain intermediate zone (Figure 5H, bracket) contains evenly dispersed small fascicles, whereas the baffled brain intermediate zone contained large swollen bundles of axons (Figure 5I, bracket and red arrowheads). It is uncertain whether these oversized bundles contain only thalamocortical axons, or corticothalamic axons as well.
The thickened disorganized axon fascicles could signify a loss of the ability of TCAs to defasciculate or to interact with the appropriate substrate. The problem appears to arise before the TCAs reach the CSB, but may result in stalling at the CSB. Therefore, the baffled mutant may represent a disruption in both step 3, defasciculating and fanning out within the ventral telencephalon, and step 4, crossing the CSB. This unusual TCA phenotype most closely resembles the TCA defects reported in the Tbr1 and Fezf2 transcription factor knockouts [22–25]. However, baffled mapped to an independent locus on chromosome 2, which does not contain a known TCA guidance gene, between D2Mit203 and a marker '58-3' we designed (see Materials and methods).
Aside from the dramatic and very consistent TCA defect, baffled mutants had other highly penetrant phenotypes. baffled mutants had small kidneys (100%; 27 of 27), hematoma under the nose (95%; 20 of 21), and those collected after birth died within hours (100%; 15 of 15). Heterozygotes appeared normal, indicating a recessive mutation. All phenotypes segregated together and were mapped to the same interval, indicating that they are caused by the same genetic lesion. Candidate genes in the interval are under investigation.
wanderer mutants display TCA fascicles misrouted onto the ventral forebrain surface
The wanderer mutant forebrains had a consistent distinctively abnormal shape. The small oval cortical hemispheres barely touched at the midline, and the olfactory bulbs were short and conical (Figure 6A). The hippocampus was also reduced, but the midbrain and hindbrain appeared normal. Other than a slightly flattened forehead, craniofacial features were normal. The kidneys were small, and any mutants born died within a few hours. The forebrain and kidney phenotypes were fully penetrant (n > 30 mutants), and heterozygotes appeared identical to wild types, indicating a fully penetrant recessive mutation.
In addition to the abnormal forebrain morphology, a striking TCA pathfinding phenotype was observed in wanderer mutant brains. A significant reduction of thalamocortical innervation was suggested by reduced beta-galactosidase staining in dorsal cortex (Figure 6A). Coronal views revealed that a subset of TCAs was misrouted ventrally out of the internal capsule (Figure 3E and 6C). Staining for neurofilament-M, which labels many axons, including TCAs and corticothalamic axons, showed a similar aberrant fascicle adjacent to the DTB (Figure 6E, red arrow). However, in contrast to fuddle and magoo mutants, in which ventrally misrouted axons stalled within ventral telencephalon, the wanderer misrouted TCA fascicle grew down onto the ventral forebrain surface and continued in a lengthy rostral trajectory (Figure 6F, G). The fascicle sometimes diverged into multiple bundles (Figure 6F, G, short red arrows). Aberrant ventral surface axons were always observed in both hemispheres in mutants, but never in heterozygotes or wild types (n = 12 -/- and n > 50 +/+ and +/- brains). However, the proportion, number, and precise pathways of the misrouted axons varied. In most mutant hemispheres about half of the axons were misrouted, but one mutant hemisphere had a complete misrouting of all TCAs ventrally with none innervating the cortex (data not shown). Usually the aberrant fascicles grew in a rostro-lateral trajectory; the longest grew all the way to the olfactory bulbs to terminate in bouton structures on the ventral side (Figure 6G, long red arrows). Occasionally a misrouted fascicle stayed in the diencephalon and grew medially along the optic tract (Figure 6G, wide red arrow), but none grew caudally.
The optic tract axons, which are labeled by the TCA-TLZ transgene as well as neurofilament, grow from the optic chiasm up the side of the diencephalon near the point where the wanderer misrouted TCAs surface on the medial margin of the ventral forebrain (Figure 6B-I, ot). To ascertain whether the optic tract axons were normal or might contribute to the aberrant fascicles in wanderer mutants, the caudal cortex overlying dorsal thalamus was removed to expose the lateral side of the diencephalon (Figure 6HI). The optic tract could be seen coursing up from the optic chiasm on the side of the thalamus to the dorsolateral geniculate nucleus in both control and mutant brains (6 H, I, black arrows). TCAs were seen in both control and mutant exiting dorsal thalamus rostral to the optic tract and then curving toward the neocortex. However, the wanderer mutants also showed a TCA fascicle that extended ventrally from the internal capsule and curved rostro-laterally on the ventral surface (Figure 6I, red arrows). A similar pattern was observed in 6 of 6 dissected wanderer mutant hemispheres. These data suggest that the optic tract axons are guided normally in wanderer mutants and that the aberrant ventral surface fascicles contain only TCAs.
wanderer mutants are homozygous for a nonsense mutation in Emx2
To determine whether wanderer represented a known or a new thalamocortical development gene, the mutation was mapped and found on distal chromosome 19 beyond D19Mit1. This 6.3-Mb interval contains the well-known cortical development gene Emx2 (Figure 7A, left). Since Emx2 knockout mice have a small cortex, small olfactory bulbs, ventral TCA misrouting, kidney dysgenesis, and perinatal lethality, Emx2 was a prime candidate gene. Also, the distinctive shape of the wanderer mutant forebrain was remarkably similar to that of the Emx2 knockout (compare Figure 6A here to Figure 2 in ). Sequencing of Emx2 from genomic DNA of wanderer mutants identified a T to A mutation near the end of the first coding exon (Figure 7A, right). This mutation is predicted to convert residue 130 (Tyr) to a stop codon and result in nonsense-mediated decay, or a protein truncated before the homeodomain and unable to bind DNA. Either way, this allele should act as a null.
To prove that this nonsense mutation in Emx2 indeed causes the wanderer mutant phenotype, we performed a genetic complementation test between wanderer mutants and Emx2 knockouts, which have a deletion/insertion in the homeodomain . Heterozygotes for the two alleles were crossed, and progeny were analyzed at day E18.5. Trans-heterozygotes had a visible phenotype indistinguishable from either of the single homozygous mutants, including the distinctively shaped small cortex and olfactory bulbs, and kidney hypoplasia (n = 8 out of 8 trans-heterozygotes). Three of them also carried the TCA-TLZ transgene, which showed long TCA fascicles growing on the ventral forebrain surface (Figure 7B). The failure of the two alleles to complement confirmed that the wanderer point mutation in Emx2 is causative for the wanderer phenotype, and that it behaves as a recessive loss of function mutation.
Surprisingly, the long TCA fascicles on the forebrain ventral surface that appeared striking to us had not been reported in prior studies of the TCA guidance defect in Emx2 knockout mutants [42, 43]. To ascertain whether this phenotype was present in the homozygous Emx2 knockout brains independent of the wanderer mutation, we crossed the TCA-TLZ reporter into the Emx2 deletion line. Indeed, in brains from homozygous knockout (ko/ko) animals carrying the reporter, TCA-TLZ fascicles were seen growing in a rostral trajectory on the ventral surface of the forebrain, just as in wan/wan or wan/ko brains (n = 8 of 8 ko/ko hemispheres).
To control for the further possibility that the TCA ventral surface fascicles could be synthetically caused by the tau-lacZ transgene, carbocyanine dye tracing was used as an independent method to trace the TCAs. Dye crystal placement in the dorsal thalamus was performed in both Emx2 knockout animals that had not been crossed to the TCA-TLZ reporter line, and wanderer mutants that did not carry the reporter. In nearly all mutant cases, aberrant dye-labeled fascicles extended rostrally on the ventral surface of the forebrain (Figure 7DE, arrows; 6 out of 6 knockout hemispheres, 5 out of 6 wanderer hemispheres). The longest mutant TCAs labeled with DiI were just barely detectable curving toward the olfactory bulb on the whole-mounts. By contrast, heterozygous and wild-type littermate brains (Figure 7C) never exhibited the ventral surface fascicles (for Emx2 knockout, 0 of 16 ko/+ hemispheres, 0 of 12 +/+ hemispheres; for wanderer, 0 of 10 +/wan hemispheres, 0 of 6 +/+ hemispheres). These findings confirm that loss of Emx2 results in some TCAs growing to distant aberrant targets on the ventral forebrain surface, and that wanderer has the same TCA phenotype as the Emx2 knockout.
We designed a forward genetic strategy to screen directly for mutants with abnormal axon projections inside the mammalian brain. Focusing on the thalamocortical system, we screened with a new reporter line for TCAs. The TCA labeling served not only as a direct indicator of TCA pathfinding abnormalities, but also as an indirect readout of forebrain development defects. Despite the small size of this ENU mutagenesis, independent mutant defects were found at distinct steps of TCA guidance and in forebrain morphogenesis. Mapping indicated that some mutants represent novel genes, and a novel phenotype was caused by mutation of the known thalamocortical development gene Emx2. The various phenotypes suggest hypotheses about latent affinities, prerequisites, and the most vulnerable choice points of thalamocortical axons.
Comparison of the TCA-TLZ reporter to other methods for labeling TCAs
The TCA-TLZ reporter line provides a valuable genetic tool for studying development of TCAs. It has some advantages over other methods for labeling TCAs, such as lipophilic dye tracing, or L1-CAM or neurofilament-M (NFM) antibodies, especially for surveying a large number of embryos. First, this reporter allows visualization of TCAs in whole or half-brains without sectioning or lengthy staining protocols. A second significant feature of this reporter is that it labels virtually all TCAs in every case, with consistent but specific labeling. By contrast, dye tracing is inherently variable in the location and number of cells labeled, and L1 or NFM immunostaining labels many axon tracts. Perhaps most importantly, the TCA-TLZ reporter marks TCAs but not corticothalamic axons, which follow overlapping pathways and cannot be distinguished by immunostaining or dye tracing after age E16.
Mutants reveal vulnerable choice points during thalamocortical axon navigation
Along their pathway, TCAs have two major turning points between segments of relatively straight growth: at the DTB (step 2) and at the CSB (step 4). These boundaries are defined by abrupt gene expression changes . To cross them, growth cones expand and slow down, perhaps adjusting their affinities for molecular and cellular substrates [8, 12, 45]. Errors seem to be prevalent at these points: many TCA pathfinding phenotypes from existing knockouts and from this screen cluster near these boundaries.
Making the sharp turn to cross the DTB (step 2) appears to be the step most vulnerable to genetic disruption. While Mash1 or Pax6smalleye mutants have complete failure of this step [14, 46], several other mutants, including fuddle, magoo, and wanderer, have partial ventral misrouting of TCAs at the DTB (Figure 3C-E, 4, 5, and 6). These data suggest that many factors are required for successful navigation at this turning point. One clear requirement for TCAs to cross the DTB is the presence of the internal capsule guidepost cells . One candidate for mediating this interaction is the protocadherin Celsr3 . However, the nature of the guidepost cells and the mechanism of their interaction with TCAs remain obscure.
The guidepost cells have also been proposed to facilitate the defasciculation and fanning out of TCAs within ventral telencephalon (step 3) . To defasciculate, the axons may need to switch adhesion preference from one another to the guidepost cells. Alternatively, the spreading of the axon bundle could be mediated by the corridor cells, and/or the gradients of netrin and ephrins in the ventral telencephalon. The relationships and particular roles of these various guidance cells and molecules need to be clarified in future investigations. The TCA overfasciculation, disorganization, and stalling observed in lateral vTel in the sprawl and baffled mutants (Figure 3F, G) could result from TCAs' failure to interact with any of these intermediate targets, and the future identification of the mutant genes may help to sort out these mechanisms.
We hypothesize that TCA defasciculation in vTel may be a prerequisite for crossing the CSB, since the thicker bundles seen in sprawl and especially baffled mutants appeared to stall before or near the CSB (Figure 3F, G and 5). Alternatively, the reduced crossing may indicate disruption of a guidance cue there, or the mutant TCAs' ability to detect it. Very little is known about the factors guiding TCA crossing and turning at the CSB. Descending subplate axons [23, 48], or ascending lateral ganglionic eminence cell axons  have been proposed as substrates, but evidence is indirect, early markers for those cells are lacking, and the question remains as to what guides those pioneer axons. Understanding the defects in mutants such as baffled or sprawl could help elucidate these mechanisms.
The TCA-TLZ reporter reveals an undiscovered aspect of the Emx2 null phenotype
The wanderer mutant was found to carry a nonsense mutation in the well-studied cortical development gene Emx2. This finding demonstrates that our screen strategy can identify important thalamocortical development genes, and moreover, that the TCA-TLZ reporter can reveal new details of TCA phenotypes even for well-known genes.
Previous studies of Emx2 knockouts did not describe TCA fascicles extended on the ventral surface of the forebrain, despite detailed dye tracing analysis of the TCA phenotype [42, 43]. The thin distal segments of the ventral surface TCA fascicles may have escaped detection in thin cross-sections, or they may not have been consistently labeled due to the inherent variability in dye crystals. By contrast, the TCA-TLZ reporter allowed us to examine TCAs in whole-mount brains, and labeled all TCAs consistently (Figure 6).
The secondary behavior of Emx2 mutant TCAs we observed after proximal failure to turn laterally at the DTB may reveal latent affinities of the axons. The derailed TCAs were capable of distant extension to incorrect targets. Some stayed in diencephalon and followed the optic tract. Most entered the telencephalon and curved rostrolaterally, some as far as the olfactory bulbs (Figure 6G). Although the olfactory bulbs are not normally connected to thalamus, the wandering TCAs may be attracted to cues for the lateral olfactory tract axons, which normally travel from olfactory bulb to piriform cortex. Indeed, both TCAs and lateral olfactory tract axons respond to slits and netrins [10, 49].
The initial turning error of TCAs in Emx2 mutants suggests that Emx2 is required to ensure that all TCAs turn laterally after crossing the DTB. Emx2 is not expressed in the thalamocortical projection neurons , so its effect on TCAs must be non-autonomous. The gene is highly expressed in the cortex, but narrow Emx2 expression domains have also been found adjacent to the TCA path near the DTB crossing, in the hypothalamus and a narrow strip of medial ventral telencephalon [42, 50]. This expression combined with the turning defect suggests that Emx2 acts non-autonomously to regulate guidance factors for TCAs at this choice point. A specific role in positioning the internal capsule guidepost cells has been proposed, since they appeared displaced in Emx2 knockout brains . Further elucidation of this relationship requires molecular markers for the guidepost cells and discovery of Emx2's transcriptional targets in this ventral telencephalon domain.
Efficacy of forward genetics combined with a strong axonal reporter
Only about half of the approximately 25,000 protein-encoding genes listed in the Mouse Genome Informatics database have been mutated or even include experimentally based functional annotations . To identify genes and phenotypes related to a specific biological process, the forward genetic approach is complementary to targeted deletions and gene trapping. First, ENU mutagenesis is unbiased with regard to genes since ENU induces point mutations randomly, without hotspots as for gene traps or homologous recombination. Second, several types of alleles are possible with ENU, allowing for partial losses of function and a potentially wider range of phenotypes, which may aid comparisons with human patients. The main drawback of the forward genetic approach, the need for positional cloning, has been rendered straightforward by the mouse genome project, and will be further simplified by the rapidly falling cost of exome and genome sequencing [52, 53].
Nevertheless, a successful neurodevelopment screen requires an efficient method to ascertain abnormal phenotypes among thousands of normal specimens. While invertebrate models such as Caenorhabditis elegans are transparent, the late-gestation mouse brain is opaque and normally must be sectioned and stained to visualize internal axon tracts. By taking advantage of the TCA-TLZ axonal reporter line first described here, we were able to screen thousands of late-gestation embryos efficiently for axonal phenotypes within the brain. Though many other central nervous system reporter lines [54, 55] do not show strong prenatal expression, any that do could also be useful in genetic screens.
Our data suggest a high yield of phenotypes from limited mutagenesis. From 57 lines we found 11 with reproducible late embryonic developmental phenotypes (19%), including 7 affecting the brain (12%). This yield is far higher than in screens for dominant behavioral mouse mutants [56–58], but falls in the range of the few recessive neurodevelopment mouse screens that have been published. For example, mouse screens in younger embryos for interneuron migration defects or peripheral nerve defects identified phenotypes in 3% to 17% of the G1 lines [59–62]. The productivity of a particular mouse screen may reflect the developmental stage examined, the range of phenotypes collected, the sensitivity of the assay, and the number of singly mutable genes required for the process under investigation.
Thalamocortical development is a rich genetic target due to the many steps and cellular interactions required over several days of axon growth through the growing forebrain. Since each G1 line is estimated to carry 30 gene-inactivating mutations [63, 64], our screen of 57 lines assayed approximately 1,700 genes, or only 6% of the genome. Thus, many more thalamocortical development and forebrain morphogenesis genes remain to be found through this strategy.
This screen represents the first attempt at an unbiased assay of the genetic requirements for development of a particular axon tract inside the mammalian brain. Despite assaying only a small fraction of the mouse genome, a variety of phenotypes were found in thalamic axon pathfinding and cortical morphogenesis. The phenotypes represent some novel genes as well as enhanced detection of the known Emx2 phenotype. This work paves the way for a more refined understanding of the interactions that TCAs must negotiate on their path through the growing forebrain, and for future genetic screens on other aspects of mammalian brain connectivity and morphogenesis.
Materials and methods
TCA-TLZ reporter line construction
A transgene was constructed using the 1.3-kb golli promoter  fused to the tau-lacZ gene . Linearized plasmid was injected into CB6F1 (BALB/c × C57BL/6) egg pronuclei, and eggs implanted into pseudopregnant females (Salk Transgenic Core Facility). Animals carrying the transgene were ascertained by genotyping tail DNA for the presence of the LacZ gene. If an animal transmitted the transgene to its progeny, they were examined for expression of the transgene by either X-Gal staining or by RNA in situ hybridization for LacZ transcript at P0. Out of five transmitting lines, only two showed detectable transgene expression, none in the cortex. One line expressed beta-galactosidase activity in the dorsal thalamus, and was called the 'TCA-TLZ' line and maintained on C57BL/6J.
Animals and breeding
Embryonic ages were estimated by plug checking (day of plug considered E0.5). Embryos were harvested by caesarean section. Littermate mouse embryos were used as controls for all experiments. Mouse colonies were maintained at the Salk Institute, Brigham and Women's Hospital, and University of Virginia in accordance with National Institutes of Health guidelines and local Institutional Animal Care and Use Committee (IACUC) protocols.
ENU injections and screening
Heterozygous TCA-TLZ males (n = 39) on a C57BL/6 background were treated with three intraperitoneal injections of either 85 or 90 mg/kg ENU (Sigma, N-3385, Sigma-Aldrich, St. Louis, MO, USA) administered once a week for 3 weeks . Dosages were quantified by spectrophotometry. Of the 39 treated males, 15 survived and recovered fertility between 12 and 16 weeks after the third ENU injection and were bred to wild-type FVB/N females (Taconic, Hudson, NY, USA). G1 males were genotyped for lacZ and only carriers selected.
E18.5 G3 embryos were collected, decapitated, and numbered. Tail or skin tissue was saved for DNA isolation. Brains were fixed for 30 minutes in 4% paraformaldehyde in phosphate-buffered saline, cut coronally with a razor blade in the approximate position of the internal capsule, fixed for five more minutes, stained in 0.8 mg/ml X-Gal solution overnight, and examined with bright field stereomicroscopy. Some brains (Figure 1A) were sectioned by vibratome before staining. Results were documented using either a Leica MZ-12 stereomicroscope using a Leica DC500 digital camera, a Leica MZ-16 stereomicroscope with DFC350 digital camera, or an Olympus stereoscope with 35 mm film camera.
Genetic linkage mapping
Genomic DNA was prepared either by standard proteinase K extraction for microsatellite markers or using the PUREGENE Purification Kit (Gentra Systems, Inc., Minneapolis, MN, USA) for SNP genotyping. SNP genotyping and data analysis were performed as described , at the Partners Healthcare Center for Personalized Genomic Medicine (PCPGM) and the Broad Institute Center for Genotyping and Analysis. SNP panels used were a 394 SNP panel (Sequenom, Inc., San Diego, CA, USA) , and a 768 SNP panel (Illumina GoldenGate, Illumina, Inc., San Diego, CA, USA). Additionally Line ND71 was genotyped on Illumina LD377 SNP and MD1449 SNP panels in a pilot. dChip software [66, 67] was used to visualize the data. Confirmation of SNP results and fine mapping were performed using polymorphic SSLP markers analyzed by PCR on genomic DNA and 3.3% MetaPhor agarose gels.
To define the right end of the baffled interval, we designed a new SSLP marker consisting of (GAAA) repeats that we named '58-3' at 34.8 Mb within an intron of the Hc gene. Left primer is CCCCTCCGCTTTTCTTTATG; right primer TTGCAAGCATAGCCTCATGT. Fuddle was mapped between D19Mit16 and D19Mit88. Map positions for lines ND91(sprawl) and ND33(bumpy) could not be determined.
Three additional recessive mutants with highly penetrant developmental phenotypes in non-brain tissues were found and mapped. ND3 mutants had stiff dry skin and mapped to chromosome 4: 118 to 143 Mb by SNP analysis. ND24 mutants exhibited cleft palates and mapped between D11Mit30 and D11Mit33. Mutants in line ND94 were anemic and mapped to chromosome 1: 156 to 185 Mb by SNPs.
Sequencing of wanderer
The exons and splice junctions of candidate genes Emx2 and Attractin-like-1 (Atrl1) were sequenced from genomic DNA of mutants and compared to the reference C57BL6 sequence (UCSC Genome Browser ). Primers were designed using Primer3 . Exons were amplified by PCR, purified with the Agencourt AMPure kit (Beckman Coulter Genomics, Danvers, MA, USA), and sequenced bidirectionally (SeqWright, Houston, TX, USA). The mutation was confirmed absent in parental strains, homozygous in all mutants and heterozygous in all carriers tested. All trans-heterozygotes from the Emx2 complementation test were confirmed by sequencing.
Dye tracing and histology
For dye tracing of thalamic axons, embryos were fixed by perfusion with 4% paraformaldehyde, brains dissected out, and a razor blade was used to make a coronal cut caudal to the thalamus. Large DiI-C18 crystals (1,1'-dioctadecyl-3,3,3',3'-teramethylindocarbocyanine perchlorate; Molecular Probes, Invitrogen Corporation, Carlsbad, CA, USA) were placed into dorsal thalamus from the caudal side to label most of the dorsal thalamus. Dye was allowed to transport for 2 weeks at 37°C. Brains were imaged whole and phenotypes confirmed by examining vibratome sections. For histochemistry, brains were fixed in 4% paraformaldehyde, and either embedded in paraffin, sectioned at 5 microns, and stained with hematoxylin and eosin (Beth Israel Histology Core), or frozen and cryosectioned at 16 microns for immunostaining. Neurofilament immunohistochemistry (NFM (2H3), 1:100; Developmental Studies Hybridoma Bank) was done on paraffin sections, and L1 immunohistochemistry (Rat anti-L1, 1/5,000; Millipore, Billerica, MA, USA) was done on cryosections, using avidin-biotin reaction (Vector Laboratories, Inc., Burlingame, CA, USA) with DAB substrate as in , or an Alexa488 secondary antibody (Figure 5F, G). Photographs were taken with either a Leica MZ12 microscope or a Leica MZ16 fluorescent microscope and Leica DFC300FX digital camera and Photoshop. In situ hybridization in Additional file 1 was performed using a radioactive probe for mRNA to the lacZ gene, as described in . Each control-mutant pair was photographed at the same magnification.
single nucleotide polymorphism
Miller B, Chou L, Finlay BL: The early development of thalamocortical and corticothalamic projections. J Comp Neurol. 1993, 335: 16-41. 10.1002/cne.903350103.
Leventer RJ, Guerrini R, Dobyns WB: Malformations of cortical development and epilepsy. Dialogues Clin Neurosci. 2008, 10: 47-62.
Sim K, Cullen T, Ongur D, Heckers S: Testing models of thalamic dysfunction in schizophrenia using neuroimaging. J Neural Transm. 2006, 113: 907-928. 10.1007/s00702-005-0363-8.
Welsh RC, Chen AC, Taylor SF: Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia. Schizophr Bull. 2010, 36: 713-722. 10.1093/schbul/sbn145.
Lopez-Bendito G, Molnar Z: Thalamocortical development: how are we going to get there?. Nat Rev Neurosci. 2003, 4: 276-289. 10.1038/nrn1075.
Hanashima C, Molnar Z, Fishell G: Building bridges to the cortex. Cell. 2006, 125: 24-27. 10.1016/j.cell.2006.03.021.
Price DJ, Kennedy H, Dehay C, Zhou L, Mercier M, Jossin Y, Goffinet AM, Tissir F, Blakey D, Molnar Z: The development of cortical connections. Eur J Neurosci. 2006, 23: 910-920. 10.1111/j.1460-9568.2006.04620.x.
Braisted JE, Tuttle R, O'Leary DD: Thalamocortical axons are influenced by chemorepellent and chemoattractant activities localized to decision points along their path. Dev Biol. 1999, 208: 430-440. 10.1006/dbio.1999.9216.
Bagri A, Marin O, Plump AS, Mak J, Pleasure SJ, Rubenstein JL, Tessier-Lavigne M: Slit proteins prevent midline crossing and determine the dorsoventral position of major axonal pathways in the mammalian forebrain. Neuron. 2002, 33: 233-248. 10.1016/S0896-6273(02)00561-5.
Braisted JE, Ringstedt T, O'Leary DD: Slits are chemorepellents endogenous to hypothalamus and steer thalamocortical axons into ventral telencephalon. Cereb Cortex. 2009, 19 (Suppl 1): i144-151. 10.1093/cercor/bhp035.
Lopez-Bendito G, Flames N, Ma L, Fouquet C, Di Meglio T, Chedotal A, Tessier-Lavigne M, Marin O: Robo1 and Robo2 cooperate to control the guidance of major axonal tracts in the mammalian forebrain. J Neurosci. 2007, 27: 3395-3407. 10.1523/JNEUROSCI.4605-06.2007.
Metin C, Godement P: The ganglionic eminence may be an intermediate target for corticofugal and thalamocortical axons. J Neurosci. 1996, 16: 3219-3235.
Mitrofanis J, Baker GE: Development of the thalamic reticular and perireticular nuclei in rats and their relationship to the course of growing corticofugal and corticopetal axons. J Comp Neurol. 1993, 338: 575-587. 10.1002/cne.903380407.
Tuttle R, Nakagawa Y, Johnson JE, O'Leary DD: Defects in thalamocortical axon pathfinding correlate with altered cell domains in Mash-1-deficient mice. Development. 1999, 126: 1903-1916.
Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, Scherz P, Skarnes WC, Tessier-Lavigne M: Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature. 2001, 410: 174-179. 10.1038/35065539.
Little GE, Lopez-Bendito G, Runker AE, Garcia N, Pinon MC, Chedotal A, Molnar Z, Mitchell KJ: Specificity and plasticity of thalamocortical connections in Sema6A mutant mice. PLoS Biol. 2009, 7: e98-10.1371/journal.pbio.1000098.
Lopez-Bendito G, Cautinat A, Sanchez JA, Bielle F, Flames N, Garratt AN, Talmage DA, Role LW, Charnay P, Marin O, Garel S: Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell. 2006, 125: 127-142. 10.1016/j.cell.2006.01.042.
Dufour A, Seibt J, Passante L, Depaepe V, Ciossek T, Frisen J, Kullander K, Flanagan JG, Polleux F, Vanderhaeghen P: Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes. Neuron. 2003, 39: 453-465. 10.1016/S0896-6273(03)00440-9.
Garel S, Yun K, Grosschedl R, Rubenstein JL: The early topography of thalamocortical projections is shifted in Ebf1 and Dlx1/2 mutant mice. Development. 2002, 129: 5621-5634. 10.1242/dev.00166.
Powell AW, Sassa T, Wu Y, Tessier-Lavigne M, Polleux F: Topography of thalamic projections requires attractive and repulsive functions of Netrin-1 in the ventral telencephalon. PLoS Biol. 2008, 6: e116-10.1371/journal.pbio.0060116.
Torii M, Levitt P: Dissociation of corticothalamic and thalamocortical axon targeting by an EphA7-mediated mechanism. Neuron. 2005, 48: 563-575. 10.1016/j.neuron.2005.09.021.
Hevner RF, Miyashita-Lin E, Rubenstein JL: Cortical and thalamic axon pathfinding defects in Tbr1, Gbx2, and Pax6 mutant mice: evidence that cortical and thalamic axons interact and guide each other. J Comp Neurol. 2002, 447: 8-17. 10.1002/cne.10219.
Hevner RF, Shi L, Justice N, Hsueh Y, Sheng M, Smiga S, Bulfone A, Goffinet AM, Campagnoni AT, Rubenstein JL: Tbr1 regulates differentiation of the preplate and layer 6. Neuron. 2001, 29: 353-366. 10.1016/S0896-6273(01)00211-2.
Komuta Y, Hibi M, Arai T, Nakamura S, Kawano H: Defects in reciprocal projections between the thalamus and cerebral cortex in the early development of Fezl-deficient mice. J Comp Neurol. 2007, 503: 454-465. 10.1002/cne.21401.
Hirata T, Suda Y, Nakao K, Narimatsu M, Hirano T, Hibi M: Zinc finger gene fez-like functions in the formation of subplate neurons and thalamocortical axons. Dev Dyn. 2004, 230: 546-556. 10.1002/dvdy.20068.
Bicknese AR, Sheppard AM, O'Leary DD, Pearlman AL: Thalamocortical axons extend along a chondroitin sulfate proteoglycan-enriched pathway coincident with the neocortical subplate and distinct from the efferent path. J Neurosci. 1994, 14: 3500-3510.
Catalano SM, Robertson RT, Killackey HP: Individual axon morphology and thalamocortical topography in developing rat somatosensory cortex. J Comp Neurol. 1996, 367: 36-53. 10.1002/(SICI)1096-9861(19960325)367:1<36::AID-CNE4>3.0.CO;2-K.
Molnar Z, Adams R, Goffinet AM, Blakemore C: The role of the first postmitotic cortical cells in the development of thalamocortical innervation in the reeler mouse. J Neurosci. 1998, 18: 5746-5765.
Catalano SM, Robertson RT, Killackey HP: Early ingrowth of thalamocortical afferents to the neocortex of the prenatal rat. Proc Natl Acad Sci USA. 1991, 88: 2999-3003. 10.1073/pnas.88.8.2999.
Herron BJ, Lu W, Rao C, Liu S, Peters H, Bronson RT, Justice MJ, McDonald JD, Beier DR: Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. Nat Genet. 2002, 30: 185-189. 10.1038/ng812.
Kasarskis A, Manova K, Anderson KV: A phenotype-based screen for embryonic lethal mutations in the mouse. Proc Natl Acad Sci USA. 1998, 95: 7485-7490. 10.1073/pnas.95.13.7485.
Moran JL, Bolton AD, Tran PV, Brown A, Dwyer ND, Manning DK, Bjork BC, Li C, Montgomery K, Siepka SM, Vitaterna MH, Takahashi JS, Wiltshire T, Kwiatkowski DJ, Kucherlapati R, Beier DR: Utilization of a whole genome SNP panel for efficient genetic mapping in the mouse. Genome Res. 2006, 16: 436-440. 10.1101/gr.4563306.
Callahan CA, Thomas JB: Tau-beta-galactosidase, an axon-targeted fusion protein. Proc Natl Acad Sci USA. 1994, 91: 5972-5976. 10.1073/pnas.91.13.5972.
Landry CF, Pribyl TM, Ellison JA, Givogri MI, Kampf K, Campagnoni CW, Campagnoni AT: Embryonic expression of the myelin basic protein gene: identification of a promoter region that targets transgene expression to pioneer neurons. J Neurosci. 1998, 18: 7315-7327.
Angevine JB: Time of neuron origin in the diencephalon of the mouse. An autoradiographic study. J Comp Neurol. 1970, 139: 129-187. 10.1002/cne.901390202.
Caviness VS, Sidman RL: Time of origin or corresponding cell classes in the cerebral cortex of normal and reeler mutant mice: an autoradiographic analysis. J Comp Neurol. 1973, 148: 141-151. 10.1002/cne.901480202.
Smits P, Bolton AD, Funari V, Hong M, Boyden ED, Lu L, Manning DK, Dwyer ND, Moran JL, Prysak M, Merriman B, Nelson SF, Bonafe L, Superti-Furga A, Ikegawa S, Krakow D, Cohn DH, Kirchhausen T, Warman ML, Beier DR: Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N Engl J Med. 2010, 362: 206-216. 10.1056/NEJMoa0900158.
Beltran-Valero de Bernabe D, Currier S, Steinbrecher A, Celli J, Van Beusekom E, Van Der Zwaag B, Kayserili H, Merlini L, Chitayat D, Dobyns WB, Cormand B, Lehesjoki AE, Cruces J, Voit T, Walsh CA, Van Bokhoven H, Brunner HG: Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet. 2002, 71: 1033-1043. 10.1086/342975.
Tsao CY, Mendell JR: Coexisting muscular dystrophies and epilepsy in children. J Child Neurol. 2006, 21: 148-150. 10.1177/08830738060210021601.
Yoshioka M, Higuchi Y, Fujii T, Aiba H, Toda T: Seizure-genotype relationship in Fukuyama-type congenital muscular dystrophy. Brain Dev. 2008, 30: 59-67. 10.1016/j.braindev.2007.05.012.
Pellegrini M, Mansouri A, Simeone A, Boncinelli E, Gruss P: Dentate gyrus formation requires Emx2. Development. 1996, 122: 3893-3898.
Lopez-Bendito G, Chan CH, Mallamaci A, Parnavelas J, Molnar Z: Role of Emx2 in the development of the reciprocal connectivity between cortex and thalamus. J Comp Neurol. 2002, 451: 153-169. 10.1002/cne.10345.
Mallamaci A, Muzio L, Chan CH, Parnavelas J, Boncinelli E: Area identity shifts in the early cerebral cortex of Emx2-/- mutant mice. Nat Neurosci. 2000, 3: 679-686. 10.1038/76630.
Puelles L, Kuwana E, Puelles E, Bulfone A, Shimamura K, Keleher J, Smiga S, Rubenstein JL: Pallial and subpallial derivatives in the embryonic chick and mouse telencephalon, traced by the expression of the genes Dlx-2, Emx-1, Nkx-2.1, Pax-6, and Tbr-1. J Comp Neurol. 2000, 424: 409-438. 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7.
Skaliora I, Adams R, Blakemore C: Morphology and growth patterns of developing thalamocortical axons. J Neurosci. 2000, 20: 3650-3662.
Jones L, Lopez-Bendito G, Gruss P, Stoykova A, Molnar Z: Pax6 is required for the normal development of the forebrain axonal connections. Development. 2002, 129: 5041-5052.
Zhou L, Bar I, Achouri Y, Campbell K, De Backer O, Hebert JM, Jones K, Kessaris N, de Rouvroit CL, O'Leary D, Richardson WD, Goffinet AM, Tissir F: Early forebrain wiring: genetic dissection using conditional Celsr3 mutant mice. Science. 2008, 320: 946-949. 10.1126/science.1155244.
Molnar Z, Blakemore C: How do thalamic axons find their way to the cortex?. Trends Neurosci. 1995, 18: 389-397. 10.1016/0166-2236(95)93935-Q.
Nguyen-Ba-Charvet KT, Plump AS, Tessier-Lavigne M, Chedotal A: Slit1 and slit2 proteins control the development of the lateral olfactory tract. J Neurosci. 2002, 22: 5473-5480.
Bishop KM, Garel S, Nakagawa Y, Rubenstein JL, O'Leary DD: Emx1 and Emx2 cooperate to regulate cortical size, lamination, neuronal differentiation, development of cortical efferents, and thalamocortical pathfinding. J Comp Neurol. 2003, 457: 345-360. 10.1002/cne.10550.
MGI: The Mouse Genome Informatics Database. [http://www.informatics.jax.org/mgihome/homepages/stats/all_stats.shtml]
Boles MK, Wilkinson BM, Wilming LG, Liu B, Probst FJ, Harrow J, Grafham D, Hentges KE, Woodward LP, Maxwell A, Mitchell K, Risley MD, Johnson R, Hirschi K, Lupski JR, Funato Y, Miki H, Marin-Garcia P, Matthews L, Coffey AJ, Parker A, Hubbard TJ, Rogers J, Bradley A, Adams DJ, Justice MJ: Discovery of candidate disease genes in ENU-induced mouse mutants by large-scale sequencing, including a splice-site mutation in nucleoredoxin. PLoS Genet. 2009, 5: e1000759-10.1371/journal.pgen.1000759.
Lunshof JE, Bobe J, Aach J, Angrist M, Thakuria JV, Vorhaus DB, Hoehe MR, Church GM: Personal genomes in progress: from the human genome project to the personal genome project. Dialogues Clin Neurosci. 2010, 12: 47-60.
Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR: Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000, 28: 41-51. 10.1016/S0896-6273(00)00084-2.
Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner A, Leblanc G, Hatten ME, Heintz N: A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature. 2003, 425: 917-925. 10.1038/nature02033.
Vitaterna MH, King DP, Chang AM, Kornhauser JM, Lowrey PL, McDonald JD, Dove WF, Pinto LH, Turek FW, Takahashi JS: Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science. 1994, 264: 719-725. 10.1126/science.8171325.
Weiss KC, Kim DY, Pawson CT, Cordes SP: A genetic screen for mouse mutations with defects in serotonin responsiveness. Brain Res Mol Brain Res. 2003, 115: 162-172. 10.1016/S0169-328X(03)00205-5.
Xie G, Clapcote SJ, Nieman BJ, Tallerico T, Huang Y, Vukobradovic I, Cordes SP, Osborne LR, Rossant J, Sled JG, Henderson JT, Roder JC: Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A. Genes Brain Behav. 2007, 6: 717-727. 10.1111/j.1601-183X.2007.00302.x.
Mar L, Rivkin E, Kim DY, Yu JY, Cordes SP: A genetic screen for mutations that affect cranial nerve development in the mouse. J Neurosci. 2005, 25: 11787-11795. 10.1523/JNEUROSCI.3813-05.2005.
Merte J, Wang Q, Vander Kooi CW, Sarsfield S, Leahy DJ, Kolodkin AL, Ginty DD: A forward genetic screen in mice identifies Sema3A(K108N), which binds to neuropilin-1 but cannot signal. J Neurosci. 2010, 30: 5767-5775. 10.1523/JNEUROSCI.5061-09.2010.
Lewcock JW, Genoud N, Lettieri K, Pfaff SL: The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics. Neuron. 2007, 56: 604-620. 10.1016/j.neuron.2007.09.009.
Zarbalis K, May SR, Shen Y, Ekker M, Rubenstein JL, Peterson AS: A focused and efficient genetic screening strategy in the mouse: identification of mutations that disrupt cortical development. PLoS Biol. 2004, 2: E219-10.1371/journal.pbio.0020219.
Favor J: The mutagenic activity of ethylnitrosourea at low doses in spermatogonia of the mouse as assessed by the specific-locus test. Mutat Res. 1998, 405: 221-226. 10.1016/S0027-5107(98)00139-0.
Russell WL, Kelly EM, Hunsicker PR, Bangham JW, Maddux SC, Phipps EL: Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci USA. 1979, 76: 5818-5819. 10.1073/pnas.76.11.5818.
Justice M: Mutagenesis of the mouse germline. Mouse Genetics and Transgenics - a Practical Approach. Edited by: Jackson IJ, Abbott CM. 2000, New York: Oxford University Press, Inc, 185-215.
Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C: dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics. 2004, 20: 1233-1240. 10.1093/bioinformatics/bth069.
dChip Software. [http://biosun1.harvard.edu/complab/dchip/]
UCSC Genome Browser. [http://genome.ucsc.edu]
Liu Q, Dwyer ND, O'Leary DD: Differential expression of COUP-TFI, CHL1, and two novel genes in developing neocortex identified by differential display PCR. J Neurosci. 2000, 20: 7682-7690.
We thank Bareza Rasoul, Ayushma Shrestha, Andrew Bolton and Alison Brown for technical assistance, and members of the Walsh and Beier labs for helpful discussions. This research was supported by grants from the National Institutes of Health (HD36404 and U01 HD43430 to DRB; K01MH69647 to NDD; R01NS35129 to CAW; R01 NS31558 and R01 MH086147 to D'OL) and a Damon Runyon Foundation fellowship (NDD). CAW is an Investigator of the Howard Hughes Medical Institute.
The authors declare that they have no competing interests.
NDD conceived and coordinated the projects. NDD and DO'L created the TCA-tau-lacZ reporter mouse. DRB and JLM designed the mapping strategy. NDD, DKM, RM, JLM, MSF, CBF, and VMV performed experiments and collected and analyzed data. NDD wrote the paper. DO'L, CAW, and DRB provided guidance and helped edit the manuscript.
Electronic supplementary material
Additional file 1: Supplement to Figure 1: TCA-TLZ transgene is expressed in the dorsal but not ventral thalamus. (A) A rostral to caudal series of coronal vibratome sections (200 μm) of a P1 TCA-TLZ brain was stained with X-Gal to reveal the thalamic pattern of the TCA-TLZ transgene expressing tau-beta-galactosidase. Expression can be seen in the primary sensory thalamic nuclei, as well as the TCAs. (The blue cellular signal in pretectum (pre) and entorhinal cortex (ent) is not due to TCA innervation or other axons.) (B) A similar coronal series of cryosections (20 μm) through the thalamus of a P1 TCA-TLZ brain was probed for lacZ mRNA by in situ hybridization to allow clearer delineation of thalamic nuclei without axons stained. All of the primary dorsal thalamic nuclei, those that project axons to cortex, express the transgene. Abbreviations: ant, anterior nucleus; dLG, dorsolateral geniculate nucleus; ent, entorhinal cortex; hip, hippocampus; LD, laterodorsal nucleus; LP, lateral posterior nucleus; MG, medial geniculate nucleus; Po, posterior nucleus; pre, pretectum; VL, ventrolateral nucleus; VP, ventroposterior nucleus. (PDF 529 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Dwyer, N.D., Manning, D.K., Moran, J.L. et al. A forward genetic screen with a thalamocortical axon reporter mouse yields novel neurodevelopment mutants and a distinct emx2 mutant phenotype. Neural Dev 6, 3 (2011). https://doi.org/10.1186/1749-8104-6-3
- Olfactory Bulb
- Internal Capsule
- Cortical Plate
- Reporter Line
- Dorsal Thalamus